Search

Search Constraints

You searched for: Author/Creator Li, JingWei

Search Results

1. An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials. (1st February 2021)

2. Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program. Issue 3 (13th March 2021)

3. Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis. Issue 12 (23rd August 2021)

4. The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program. (December 2019)